Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus

Abstract Background Type II diabetes mellitus (T2DM) is an important risk factor for osseointegration of implants. The aim of this study was to explore key genes of T2DM affecting bone metabolism through bioinformatic analysis of published RNA sequencing data, identify potential biomarkers, and prov...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Lingxiao Wang, Zhenhua Gao, Changying Liu, Jun Li
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/b2367f66993042d2987dcb0514ec8443
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:b2367f66993042d2987dcb0514ec8443
record_format dspace
spelling oai:doaj.org-article:b2367f66993042d2987dcb0514ec84432021-11-21T12:32:25ZPotential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus10.1186/s12903-021-01939-91472-6831https://doaj.org/article/b2367f66993042d2987dcb0514ec84432021-11-01T00:00:00Zhttps://doi.org/10.1186/s12903-021-01939-9https://doaj.org/toc/1472-6831Abstract Background Type II diabetes mellitus (T2DM) is an important risk factor for osseointegration of implants. The aim of this study was to explore key genes of T2DM affecting bone metabolism through bioinformatic analysis of published RNA sequencing data, identify potential biomarkers, and provide a reference for finding the molecular mechanism of abnormal osseointegration caused by T2DM. Methods We identified differentially expressed mRNAs and miRNAs from the Gene Expression Omnibus database using the R package ‘limma’ and analysed the predicted target genes using Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis and Gene Ontology analysis. At the same time, miRNA–mRNA interactions were explored using miRWalk 2.0. Results We constructed an miRNA-gene regulatory network and a protein–protein interaction network. The enrichment pathways of differentially expressed mRNAs included extracellular matrix receptor interactions, protein digestion and absorption, the PI3K-Akt signalling pathway, cytokine–cytokine receptor interactions, chemokine signalling pathways, and haematopoietic cell lineage functions. We analysed the expression of these differentially expressed mRNAs and miRNAs in T2DM rats and normal rats with bone implants and identified Smpd3, Itga10, and rno-mir-207 as possible key players in osseointegration in T2DM. Conclusion Smpd3, Itga10, and rno-mir-207 are possible biomarkers of osseointegration in T2DM. This study sheds light on the possible molecular mechanism of abnormal osseointegration caused by bone metabolism disorder in T2DM.Lingxiao WangZhenhua GaoChangying LiuJun LiBMCarticleBioinformatics analysisBiomarkersOsseointegrationmiRNAsT2DMDentistryRK1-715ENBMC Oral Health, Vol 21, Iss 1, Pp 1-13 (2021)
institution DOAJ
collection DOAJ
language EN
topic Bioinformatics analysis
Biomarkers
Osseointegration
miRNAs
T2DM
Dentistry
RK1-715
spellingShingle Bioinformatics analysis
Biomarkers
Osseointegration
miRNAs
T2DM
Dentistry
RK1-715
Lingxiao Wang
Zhenhua Gao
Changying Liu
Jun Li
Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
description Abstract Background Type II diabetes mellitus (T2DM) is an important risk factor for osseointegration of implants. The aim of this study was to explore key genes of T2DM affecting bone metabolism through bioinformatic analysis of published RNA sequencing data, identify potential biomarkers, and provide a reference for finding the molecular mechanism of abnormal osseointegration caused by T2DM. Methods We identified differentially expressed mRNAs and miRNAs from the Gene Expression Omnibus database using the R package ‘limma’ and analysed the predicted target genes using Kyoto Encyclopedia of Genes and Genomes pathway enrichment analysis and Gene Ontology analysis. At the same time, miRNA–mRNA interactions were explored using miRWalk 2.0. Results We constructed an miRNA-gene regulatory network and a protein–protein interaction network. The enrichment pathways of differentially expressed mRNAs included extracellular matrix receptor interactions, protein digestion and absorption, the PI3K-Akt signalling pathway, cytokine–cytokine receptor interactions, chemokine signalling pathways, and haematopoietic cell lineage functions. We analysed the expression of these differentially expressed mRNAs and miRNAs in T2DM rats and normal rats with bone implants and identified Smpd3, Itga10, and rno-mir-207 as possible key players in osseointegration in T2DM. Conclusion Smpd3, Itga10, and rno-mir-207 are possible biomarkers of osseointegration in T2DM. This study sheds light on the possible molecular mechanism of abnormal osseointegration caused by bone metabolism disorder in T2DM.
format article
author Lingxiao Wang
Zhenhua Gao
Changying Liu
Jun Li
author_facet Lingxiao Wang
Zhenhua Gao
Changying Liu
Jun Li
author_sort Lingxiao Wang
title Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
title_short Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
title_full Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
title_fullStr Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
title_full_unstemmed Potential biomarkers of abnormal osseointegration of implants in type II diabetes mellitus
title_sort potential biomarkers of abnormal osseointegration of implants in type ii diabetes mellitus
publisher BMC
publishDate 2021
url https://doaj.org/article/b2367f66993042d2987dcb0514ec8443
work_keys_str_mv AT lingxiaowang potentialbiomarkersofabnormalosseointegrationofimplantsintypeiidiabetesmellitus
AT zhenhuagao potentialbiomarkersofabnormalosseointegrationofimplantsintypeiidiabetesmellitus
AT changyingliu potentialbiomarkersofabnormalosseointegrationofimplantsintypeiidiabetesmellitus
AT junli potentialbiomarkersofabnormalosseointegrationofimplantsintypeiidiabetesmellitus
_version_ 1718418965057765376